Loading...
Hypersensitivity to mesalazine in a patient with inflammatory bowel disease: a case report
Cronin, Kevin C Colleran, Gabrielle C Smyth, Andrew Houlihan, Diarmuid D O'Gorman, Thomas A
Cronin, Kevin C
Colleran, Gabrielle C
Smyth, Andrew
Houlihan, Diarmuid D
O'Gorman, Thomas A
Citations
Altmetric:
Advisors
Editors
Other Contributors
Departments
Date
2009-08-25
Date Submitted
Keywords
INFLAMMATORY BOWEL DISEASE
Other Subjects
Subject Mesh
Planned Date
Start Date
Collaborators
Principal Investigators
Files
Alternative Titles
Publisher
Abstract
Abstract A 32-year-old male presented with diarrhoea, mucus and bleeding per rectum. On the basis of sigmoidoscopy, rectal mesalazine was commenced uneventfully, and subsequently changed to oral mesalazine due to failure to improve. He re-presented 4 days later with frequent rigors, lethargy, palpitations and was generally unwell. His condition settled with conservative management and IV antibiotics. Oral mesalazine was withheld during the first 24 hours but was recommenced on day 2. After 2 doses he developed rigors, pyrexia, tachycardia and vomiting. Oral mesalazine was discontinued thereafter and his condition progressively improved. Mesalazine has not been re-introduced.
Language
en